secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2025-02-04T23:59:59+00:00
Accession:  0001104659-25-009122
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransCode Therapeutics adjourns special meeting; only 29.94% of shares voted, below quorum
--------------------------------------------------------------------------------

- Special meeting held Feb 4, 2025 lacked quorum (needs one-third of outstanding shares); only 29.94% voted.
- Meeting reconvenes Feb 25, 2025 at 9:30 a.m. ET virtually; record date remains Dec 17, 2024.
- Proposals include approval of warrant share issuance (Series C and D) and an adjournment proposal.
- Company continues soliciting votes; stockholders can vote by mail, internet, phone, or at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925009122/0001104659-25-009122-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925009122/tm255410d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-009122

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer